4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-045279
President & Immunovant CEO sold 200,000 shares at $20.85 ($4,170,000)
- President & Immunovant CEO acquired 200,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & Immunovant CEO | 2025-12-09 | Option exercise 10b5-1 | +200,000 | $3.85 | $770,000 | 1,697,908 | D |
| Venker Eric President & Immunovant CEO | 2025-12-09 | Sale 10b5-1 | −200,000 | $20.85 | $4,170,000 | 1,497,908 | D |
| Derivatives | |||||||
| Venker Eric President & Immunovant CEO | 2025-12-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200,000 | 5,876,523 | D | ||
| Open-market sales · 200,000 sh · avg $20.85 · $4,170,000 | |||||||
Loading xslF345X05/form4.xml…